niacinamide has been researched along with Carcinoma, Oat Cell in 5 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib has demonstrated single agent activity in non-small cell (NSCLC) and small cell lung cancer (SCLC)." | 2.76 | A phase I trial of sorafenib combined with cisplatin/etoposide or carboplatin/pemetrexed in refractory solid tumor patients. ( Bernard, S; Chiu, M; Davies, JM; Dees, EC; Dhruva, NS; Hayes, DN; Hilbun, LR; Ivanova, A; Keller, K; Kim, WY; Socinski, MA; Stinchcombe, TE; Walko, CM, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beauparlant, P | 1 |
| Bédard, D | 1 |
| Bernier, C | 1 |
| Chan, H | 1 |
| Gilbert, K | 1 |
| Goulet, D | 1 |
| Gratton, MO | 1 |
| Lavoie, M | 1 |
| Roulston, A | 1 |
| Turcotte, E | 1 |
| Watson, M | 1 |
| Davies, JM | 1 |
| Dhruva, NS | 1 |
| Walko, CM | 1 |
| Socinski, MA | 1 |
| Bernard, S | 1 |
| Hayes, DN | 1 |
| Kim, WY | 1 |
| Ivanova, A | 1 |
| Keller, K | 1 |
| Hilbun, LR | 1 |
| Chiu, M | 1 |
| Dees, EC | 1 |
| Stinchcombe, TE | 1 |
| Lin, X | 1 |
| Morgan-Lappe, S | 1 |
| Huang, X | 1 |
| Li, L | 1 |
| Zakula, DM | 1 |
| Vernetti, LA | 1 |
| Fesik, SW | 1 |
| Shen, Y | 1 |
| Chaplin, DJ | 1 |
| Horsman, MR | 1 |
| Aoki, DS | 1 |
1 trial available for niacinamide and Carcinoma, Oat Cell
| Article | Year |
|---|---|
A phase I trial of sorafenib combined with cisplatin/etoposide or carboplatin/pemetrexed in refractory solid tumor patients.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonate | 2011 |
4 other studies available for niacinamide and Carcinoma, Oat Cell
| Article | Year |
|---|---|
Preclinical development of the nicotinamide phosphoribosyl transferase inhibitor prodrug GMX1777.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Cell Line, Tumor; Colonic Neo | 2009 |
'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737.
Topics: 3' Untranslated Regions; Antineoplastic Agents; Base Sequence; bcl-X Protein; Benzenesulfonates; Bip | 2007 |
ASCO 2007: plenary top 5.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinom | 2007 |
Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
Topics: Animals; Carbon Dioxide; Carcinoma, Small Cell; Cell Hypoxia; Cell Survival; Dose-Response Relations | 1991 |